Other Events ·
Eocene signs first European distribution deal for CG-100 device with Hospital Line in Greece and Cyprus
EOCNGalmed Pharmaceuticals Ltd.
Eocene Ltd. announced that its wholly owned subsidiary, Colospan Ltd., entered into an exclusive commercial distribution agreement with Hospital Line SA to market, sell, and distribute the CG-100 intraluminal bypass device in Greece and Cyprus. The partnership grants Hospital Line exclusive rights for these territories, serving as a foundation for potential expansion into additional European markets. The planned commercial launch is expected to proceed in parallel with Colospan’s ongoing U.S. pivotal study of the device. Eocene Ltd. is a gastrointestinal-focused medtech and biopharmaceutical company developing innovative solutions for colorectal care and liver disease.